bpc 157 wada banned just added tirzepatide (mounjaro) to the 2026 Monitoring Program bpc 157 banned by wada

What has changed in 2026 is the compounding classification the narrower regulatory question of whether 503A pharmacies can legally prepare BPC-157 prescriptions

Drug Interactions Because these peptides influence vascular, inflammatory, and neurological pathways, interactions with anticoagulants, NSAIDs, immunosuppressants, psychiatric medications, and other pharmaceutical agents are possible but largely unexplored

Injectable growth hormone secretagogues show modest benefits but carry metabolic side effects

the elderly, strict vegetarians (i.e., vegan), and patients with malabsorption problems are more likely to become deficient